This anti-MLLT1 antibody is a Rabbit Polyclonal antibody detecting MLLT1 in WB. Suitable for Human. This Primary Antibody has been cited in 1 publication.
MLLT1
(MLLT1, super elongation complex subunit (MLLT1))
Reactivity
Human
Host
Rabbit
Clonality
Polyclonal
Conjugate
This MLLT1 antibody is un-conjugated
Application
Western Blotting (WB)
Clone
RB1927-1928
Binding Specificity
AA 523-552, C-Term
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This MLLT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 523-552 amino acids from the C-terminal region of human MLLT1.
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date
6 months
Bitoun, Oliver, Davies: "The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling." in: Human molecular genetics, Vol. 16, Issue 1, pp. 92-106, (2007) (PubMed).
Target
MLLT1
(MLLT1, super elongation complex subunit (MLLT1))
Alternative Name
MLLT1
Background
Chromosome band 11q23 is the site of translocations in myeloid and lymphoid acute leukemias, pediatric leukemias, and treatment-induced secondary acute myelogenous leukemia. The translocation breakpoints cluster in a restricted region of the HRX gene resulting in chimeric genes that encode an N-terminal portion of Hrx fused to various partner proteins. Myeloid/lymphoid or mixed-lineage leukemia translocated to 1 (MLLT1) is a nuclear protein with transcriptional transactivation properties that is fused to Hrx in t(11,19) leukemias. The minimal MLLT1 sequence required for transcription activation was narrowed to the C-terminal 90 amino acids.